Literature DB >> 7983290

The neglected half of Alzheimer disease: cognitive and functional concomitants of severe dementia.

S R Auer1, S G Sclan, R A Yaffee, B Reisberg.   

Abstract

OBJECTIVE: Traditional mental status and psychometric assessments bottom out in the late stages of Alzheimer disease (AD). A method adapted from cognitive testing in infants, the Ordinal Scales of Psychological Development was modified (M-OSPD) and applied to a severely demented population. The concurrent validity of this method was tested in comparison with Functional Assessment Staging (FAST). Internal consistency as a measure for reliability was also determined.
DESIGN: Cross sectional study.
SETTING: Subjects were generally evaluated in their residence, usually a nursing home or a private home. PATIENTS: Severely cognitively impaired subjects who fulfilled criteria for probable AD were studied. MEASUREMENTS: Evaluation consisted of clinical global, mental status, functional, and cognitive assessments including the Global Deterioration Scale (GDS) and the Mini-Mental State Examination (MMSE).
RESULTS: Seventy patients were evaluated. Traditional mental status assessments (eg, the MMSE) manifested virtually uniform bottom scores in all GDS stage 7 subjects (n = 46), and GDS stage 6 subjects had MMSE scores within one standard deviation unit of zero. In contrast, the M-OSPD scale continued to show results in the last stages of the disease. The Spearman correlation coefficient between the M-OSPD total score and the 11 FAST substages represented in this sample was -0.77 (P < 0.001).
CONCLUSIONS: The results indicate that patients who are functionally more impaired also show continuing increments in cognitive loss. These cognitive and functional assessments for measuring the magnitude of deterioration in AD can be applied to the estimated half-million nursing home residents presently labeled "untestable" with the goal of optimization of care and residual capacities.

Entities:  

Mesh:

Year:  1994        PMID: 7983290     DOI: 10.1111/j.1532-5415.1994.tb06509.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  6 in total

1.  Executive dysfunction in Alzheimer disease.

Authors:  Margaret M Swanberg; Rochelle E Tractenberg; Richard Mohs; Leon J Thal; Jeffrey L Cummings
Journal:  Arch Neurol       Date:  2004-04

Review 2.  The BEHAVE-AD assessment system: a perspective, a commentary on new findings, and a historical review.

Authors:  Barry Reisberg; Isabel Monteiro; Carol Torossian; Stefanie Auer; Melanie B Shulman; Santosh Ghimire; Istvan Boksay; Francoise Guillo BenArous; Ricardo Osorio; Aninditha Vengassery; Sheema Imran; Hussam Shaker; Sadaf Noor; Shazia Naqvi; Sunnie Kenowsky; Jinfeng Xu
Journal:  Dement Geriatr Cogn Disord       Date:  2014-04-07       Impact factor: 2.959

Review 3.  Diagnosis and treatment of patients with severe Alzheimer's disease.

Authors:  Thierry Voisin; Bruno Vellas
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

4.  To what degree does cognitive impairment in Alzheimer's disease predict dependence of patients on caregivers?

Authors:  Jaime Caro; Alexandra Ward; Khajak Ishak; Kristen Migliaccio-Walle; Denis Getsios; George Papadopoulos; Koen Torfs
Journal:  BMC Neurol       Date:  2002-08-19       Impact factor: 2.474

5.  Brief cognitive assessment of Alzheimer's disease in advanced stages: Proposal for a Brazilian version of the Short Battery for Severe Impairment (SIB-8).

Authors:  José Roberto Wajman; Paulo Henrique Ferreira Bertolucci
Journal:  Dement Neuropsychol       Date:  2013 Apr-Jun

6.  Reliability and validity of the severe impairment battery in Taiwanese patients with moderate to severe Alzheimer's disease.

Authors:  Mao-Hsuan Huang; Chia-Fen Tsai; Chaur-Jong Hu; Yu-Te Lin; Yuan-Han Yang; Wen-Fu Wang; Wei-Ju Lee; Jong-Ling Fuh
Journal:  J Chin Med Assoc       Date:  2020-11       Impact factor: 3.396

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.